| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |